NEW YORK, April 18 - German functional genomics startup DeveloGen has raised 40 million euros ($35 million) in a round of private financing, the company said Wednesday. 

The funds will go towards expanding the company's in-house technology platform for identifying genes related to diabetes and obesity, as well as allow the company to branch out into new areas of disease, including cardiovascular disease, said Ed Stuart, DeveloGen's COO. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.